1	IL-10	IL-10	_	_	_	_	_	_	_
2	inhibits	inhibit	_	_	_	_	_	_	_
3	nuclear	nuclear	_	_	_	_	_	_	_
4	factor-kappa	factor-kappa	_	_	_	_	_	_	_
5	B/Rel	B/Rel	_	_	_	_	_	_	_
6	nuclear	nuclear	_	_	_	_	_	_	_
7	activity	activity	_	_	_	_	_	_	_
8	in	in	_	_	_	_	_	_	_
9	CD3-stimulated	cd3-stimulated	_	_	_	_	_	_	_
10	human	human	_	_	_	_	_	_	_
11	peripheral	peripheral	_	_	_	_	_	_	_
12	T	t	_	_	_	_	_	_	_
13	lymphocytes	lymphocyte	_	_	_	_	_	_	_
14	.	.	_	_	_	_	_	_	_

1	IL-10	IL-10	_	_	_	_	_	_	_
2	markedly	markedly	_	_	_	_	_	_	_
3	reduces	reduce	_	_	_	_	_	_	_
4	nuclear	nuclear	_	_	_	_	_	_	_
5	factor	factor	_	_	_	_	_	_	_
6	(	(	_	_	_	_	_	_	_
7	NF)-kappa	NF)-kappa	_	_	_	_	_	_	_
8	B/Rel	B/Rel	_	_	_	_	_	_	_
9	nuclear	nuclear	_	_	_	_	_	_	_
10	activity	activity	_	_	_	_	_	_	_
11	induced	induce	_	_	_	_	_	_	_
12	in	in	_	_	_	_	_	_	_
13	PBMC	PBMC	_	_	_	_	_	_	_
14	by	by	_	_	_	_	_	_	_
15	stimulation	stimulation	_	_	_	_	_	_	_
16	with	with	_	_	_	_	_	_	_
17	the	the	_	_	_	_	_	_	_
18	anti-CD3	anti-cd3	_	_	_	_	_	_	_
19	mAb	mab	_	_	_	_	_	_	_
20	OKT3	okt3	_	_	_	_	_	_	_
21	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	inhibition	inhibition	_	_	_	_	_	_	_
3	is	be	_	_	_	_	_	_	_
4	exerted	exert	_	_	_	_	_	_	_
5	specifically	specifically	_	_	_	_	_	_	_
6	on	on	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	NF-kappa	NF-kappa	_	_	_	_	_	_	_
9	B/Rel	B/Rel	_	_	_	_	_	_	_
10	activation	activation	_	_	_	_	_	_	_
11	induced	induce	_	_	_	_	_	_	_
12	by	by	_	_	_	_	_	_	_
13	mAb	mab	_	_	_	_	_	_	_
14	OKT3	okt3	_	_	_	_	_	_	_
15	,	,	_	_	_	_	_	_	_
16	and	and	_	_	_	_	_	_	_
17	not	not	_	_	_	_	_	_	_
18	that	that	_	_	_	_	_	_	_
19	produced	produce	_	_	_	_	_	_	_
20	by	by	_	_	_	_	_	_	_
21	PMA	PMA	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	As	as	_	_	_	_	_	_	_
2	judged	judge	_	_	_	_	_	_	_
3	by	by	_	_	_	_	_	_	_
4	supershifting	supershifte	_	_	_	_	_	_	_
5	the	the	_	_	_	_	_	_	_
6	DNA-protein	dna-protein	_	_	_	_	_	_	_
7	complexes	complex	_	_	_	_	_	_	_
8	with	with	_	_	_	_	_	_	_
9	Abs	ab	_	_	_	_	_	_	_
10	recognizing	recognize	_	_	_	_	_	_	_
11	specific	specific	_	_	_	_	_	_	_
12	components	component	_	_	_	_	_	_	_
13	of	of	_	_	_	_	_	_	_
14	the	the	_	_	_	_	_	_	_
15	NF-kappa	NF-kappa	_	_	_	_	_	_	_
16	B/Rel	B/Rel	_	_	_	_	_	_	_
17	protein	protein	_	_	_	_	_	_	_
18	family	family	_	_	_	_	_	_	_
19	,	,	_	_	_	_	_	_	_
20	the	the	_	_	_	_	_	_	_
21	p50/p65	p50/p65	_	_	_	_	_	_	_
22	(	(	_	_	_	_	_	_	_
23	Rel	Rel	_	_	_	_	_	_	_
24	A	A	_	_	_	_	_	_	_
25	)	)	_	_	_	_	_	_	_
26	heterodimeric	heterodimeric	_	_	_	_	_	_	_
27	form	form	_	_	_	_	_	_	_
28	of	of	_	_	_	_	_	_	_
29	NF-kappa	NF-kappa	_	_	_	_	_	_	_
30	B	B	_	_	_	_	_	_	_
31	is	be	_	_	_	_	_	_	_
32	primarily	primarily	_	_	_	_	_	_	_
33	affected	affect	_	_	_	_	_	_	_
34	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	maximal	maximal	_	_	_	_	_	_	_
3	effect	effect	_	_	_	_	_	_	_
4	is	be	_	_	_	_	_	_	_
5	observed	observe	_	_	_	_	_	_	_
6	at	at	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	IL-10	il-10	_	_	_	_	_	_	_
9	concentration	concentration	_	_	_	_	_	_	_
10	of	of	_	_	_	_	_	_	_
11	20	20	_	_	_	_	_	_	_
12	U/ml.	U/ml.	_	_	_	_	_	_	_
13	IL-10	IL-10	_	_	_	_	_	_	_
14	inhibitory	inhibitory	_	_	_	_	_	_	_
15	activity	activity	_	_	_	_	_	_	_
16	is	be	_	_	_	_	_	_	_
17	exerted	exert	_	_	_	_	_	_	_
18	on	on	_	_	_	_	_	_	_
19	T	t	_	_	_	_	_	_	_
20	lymphocytes	lymphocyte	_	_	_	_	_	_	_
21	and	and	_	_	_	_	_	_	_
22	is	be	_	_	_	_	_	_	_
23	mediated	mediate	_	_	_	_	_	_	_
24	by	by	_	_	_	_	_	_	_
25	monocytes	monocyte	_	_	_	_	_	_	_
26	.	.	_	_	_	_	_	_	_

1	Indeed	indeed	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	monocytes	monocyte	_	_	_	_	_	_	_
4	pretreated	pretreate	_	_	_	_	_	_	_
5	with	with	_	_	_	_	_	_	_
6	IL-10	IL-10	_	_	_	_	_	_	_
7	are	be	_	_	_	_	_	_	_
8	able	able	_	_	_	_	_	_	_
9	so	so	_	_	_	_	_	_	_
10	inhibit	inhibit	_	_	_	_	_	_	_
11	NF-kappa	NF-kappa	_	_	_	_	_	_	_
12	B	B	_	_	_	_	_	_	_
13	nuclear	nuclear	_	_	_	_	_	_	_
14	activity	activity	_	_	_	_	_	_	_
15	in	in	_	_	_	_	_	_	_
16	purified	purify	_	_	_	_	_	_	_
17	T	t	_	_	_	_	_	_	_
18	lymphocytes	lymphocyte	_	_	_	_	_	_	_
19	stimulated	stimulate	_	_	_	_	_	_	_
20	with	with	_	_	_	_	_	_	_
21	OKT3	OKT3	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	Soluble	soluble	_	_	_	_	_	_	_
2	factors	factor	_	_	_	_	_	_	_
3	do	do	_	_	_	_	_	_	_
4	not	not	_	_	_	_	_	_	_
5	appear	appear	_	_	_	_	_	_	_
6	to	to	_	_	_	_	_	_	_
7	be	be	_	_	_	_	_	_	_
8	involved	involve	_	_	_	_	_	_	_
9	in	in	_	_	_	_	_	_	_
10	the	the	_	_	_	_	_	_	_
11	mechanism	mechanism	_	_	_	_	_	_	_
12	of	of	_	_	_	_	_	_	_
13	inhibition	inhibition	_	_	_	_	_	_	_
14	.	.	_	_	_	_	_	_	_

1	On	on	_	_	_	_	_	_	_
2	the	the	_	_	_	_	_	_	_
3	other	other	_	_	_	_	_	_	_
4	hand	hand	_	_	_	_	_	_	_
5	,	,	_	_	_	_	_	_	_
6	the	the	_	_	_	_	_	_	_
7	up-regulation	up-regulation	_	_	_	_	_	_	_
8	of	of	_	_	_	_	_	_	_
9	CD80	CD80	_	_	_	_	_	_	_
10	Ag	Ag	_	_	_	_	_	_	_
11	,	,	_	_	_	_	_	_	_
12	found	find	_	_	_	_	_	_	_
13	on	on	_	_	_	_	_	_	_
14	monocytes	monocyte	_	_	_	_	_	_	_
15	obtained	obtain	_	_	_	_	_	_	_
16	from	from	_	_	_	_	_	_	_
17	PBMC	PBMC	_	_	_	_	_	_	_
18	incubated	incubate	_	_	_	_	_	_	_
19	with	with	_	_	_	_	_	_	_
20	OKT3	OKT3	_	_	_	_	_	_	_
21	,	,	_	_	_	_	_	_	_
22	is	be	_	_	_	_	_	_	_
23	not	not	_	_	_	_	_	_	_
24	detected	detect	_	_	_	_	_	_	_
25	after	after	_	_	_	_	_	_	_
26	addition	addition	_	_	_	_	_	_	_
27	of	of	_	_	_	_	_	_	_
28	IL-10	IL-10	_	_	_	_	_	_	_
29	,	,	_	_	_	_	_	_	_
30	and	and	_	_	_	_	_	_	_
31	the	the	_	_	_	_	_	_	_
32	anti-CD28	anti-cd28	_	_	_	_	_	_	_
33	mAb	mab	_	_	_	_	_	_	_
34	CLB-CD28/1	clb-cd28/1	_	_	_	_	_	_	_
35	restores	restore	_	_	_	_	_	_	_
36	the	the	_	_	_	_	_	_	_
37	NF-kappa	NF-kappa	_	_	_	_	_	_	_
38	B/Rel	B/Rel	_	_	_	_	_	_	_
39	nuclear	nuclear	_	_	_	_	_	_	_
40	activity	activity	_	_	_	_	_	_	_
41	in	in	_	_	_	_	_	_	_
42	IL-10-inhibited	il-10-inhibited	_	_	_	_	_	_	_
43	lymphocytes	lymphocyte	_	_	_	_	_	_	_
44	.	.	_	_	_	_	_	_	_

1	Therefore	therefore	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	NF-kappa	NF-kappa	_	_	_	_	_	_	_
5	B/Rel	B/Rel	_	_	_	_	_	_	_
6	inhibition	inhibition	_	_	_	_	_	_	_
7	might	might	_	_	_	_	_	_	_
8	be	be	_	_	_	_	_	_	_
9	ascribed	ascribe	_	_	_	_	_	_	_
10	to	to	_	_	_	_	_	_	_
11	a	a	_	_	_	_	_	_	_
12	lack	lack	_	_	_	_	_	_	_
13	of	of	_	_	_	_	_	_	_
14	cooperation	cooperation	_	_	_	_	_	_	_
15	between	between	_	_	_	_	_	_	_
16	accessory	accessory	_	_	_	_	_	_	_
17	cells	cell	_	_	_	_	_	_	_
18	and	and	_	_	_	_	_	_	_
19	T	t	_	_	_	_	_	_	_
20	lymphocytes	lymphocyte	_	_	_	_	_	_	_
21	,	,	_	_	_	_	_	_	_
22	resulting	result	_	_	_	_	_	_	_
23	from	from	_	_	_	_	_	_	_
24	down-regulation	down-regulation	_	_	_	_	_	_	_
25	of	of	_	_	_	_	_	_	_
26	a	a	_	_	_	_	_	_	_
27	costimulatory	costimulatory	_	_	_	_	_	_	_
28	molecule	molecule	_	_	_	_	_	_	_
29	,	,	_	_	_	_	_	_	_
30	such	such	_	_	_	_	_	_	_
31	as	as	_	_	_	_	_	_	_
32	CD80	CD80	_	_	_	_	_	_	_
33	,	,	_	_	_	_	_	_	_
34	produced	produce	_	_	_	_	_	_	_
35	by	by	_	_	_	_	_	_	_
36	IL-10	il-10	_	_	_	_	_	_	_
37	on	on	_	_	_	_	_	_	_
38	activated	activate	_	_	_	_	_	_	_
39	monocytes	monocyte	_	_	_	_	_	_	_
40	.	.	_	_	_	_	_	_	_

1	Our	our	_	_	_	_	_	_	_
2	results	result	_	_	_	_	_	_	_
3	demonstrate	demonstrate	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	IL-10	il-10	_	_	_	_	_	_	_
6	can	can	_	_	_	_	_	_	_
7	inhibit	inhibit	_	_	_	_	_	_	_
8	the	the	_	_	_	_	_	_	_
9	induction	induction	_	_	_	_	_	_	_
10	of	of	_	_	_	_	_	_	_
11	NF-kappa	NF-kappa	_	_	_	_	_	_	_
12	B/Rel	B/Rel	_	_	_	_	_	_	_
13	nuclear	nuclear	_	_	_	_	_	_	_
14	activity	activity	_	_	_	_	_	_	_
15	in	in	_	_	_	_	_	_	_
16	CD3-stimulated	cd3-stimulated	_	_	_	_	_	_	_
17	T	t	_	_	_	_	_	_	_
18	lymphocytes	lymphocyte	_	_	_	_	_	_	_
19	.	.	_	_	_	_	_	_	_

1	Since	since	_	_	_	_	_	_	_
2	inappropriate	inappropriate	_	_	_	_	_	_	_
3	activation	activation	_	_	_	_	_	_	_
4	of	of	_	_	_	_	_	_	_
5	kappa	kappa	_	_	_	_	_	_	_
6	B-driven	b-driven	_	_	_	_	_	_	_
7	genes	gene	_	_	_	_	_	_	_
8	has	have	_	_	_	_	_	_	_
9	a	a	_	_	_	_	_	_	_
10	physiopathologic	physiopathologic	_	_	_	_	_	_	_
11	role	role	_	_	_	_	_	_	_
12	in	in	_	_	_	_	_	_	_
13	a	a	_	_	_	_	_	_	_
14	number	number	_	_	_	_	_	_	_
15	of	of	_	_	_	_	_	_	_
16	diseases	disease	_	_	_	_	_	_	_
17	,	,	_	_	_	_	_	_	_
18	such	such	_	_	_	_	_	_	_
19	as	as	_	_	_	_	_	_	_
20	HIV	HIV	_	_	_	_	_	_	_
21	infection	infection	_	_	_	_	_	_	_
22	,	,	_	_	_	_	_	_	_
23	our	our	_	_	_	_	_	_	_
24	findings	finding	_	_	_	_	_	_	_
25	support	support	_	_	_	_	_	_	_
26	the	the	_	_	_	_	_	_	_
27	possibility	possibility	_	_	_	_	_	_	_
28	of	of	_	_	_	_	_	_	_
29	using	use	_	_	_	_	_	_	_
30	this	this	_	_	_	_	_	_	_
31	cytokine	cytokine	_	_	_	_	_	_	_
32	to	to	_	_	_	_	_	_	_
33	suppress	suppress	_	_	_	_	_	_	_
34	an	an	_	_	_	_	_	_	_
35	undesirable	undesirable	_	_	_	_	_	_	_
36	activation	activation	_	_	_	_	_	_	_
37	of	of	_	_	_	_	_	_	_
38	these	these	_	_	_	_	_	_	_
39	transcription	transcription	_	_	_	_	_	_	_
40	factors	factor	_	_	_	_	_	_	_
41	.	.	_	_	_	_	_	_	_

